Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.9

(-0.18%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 1.76 Billion 1.8 Billion 1.65 Billion 1.48 Billion 1.52 Billion
Total Current Assets 803.99 Million 857.63 Million 651.47 Million 683.59 Million 657.05 Million
Cash And Short Term Investments 381.04 Million 456.25 Million 252.27 Million 335.8 Million 275.19 Million
Cash and Cash Equivalents 381.04 Million 456.25 Million 252.27 Million 335.8 Million 275.19 Million
Short Term Investments - - - - -
Net Receivables 309.71 Million 285.53 Million 292.12 Million 262.39 Million 296.31 Million
Inventory 89.17 Million 99.02 Million 90.25 Million 85.39 Million 85.51 Million
Other Current Assets 19.95 Million 16.82 Million 16.82 Million 5000.00 38 Thousand
Total Non-Current Assets 962.1 Million 942.89 Million 1 Billion 803.12 Million 864.99 Million
Net PPE 720.34 Million 792.8 Million 903.7 Million 721.21 Million 775.77 Million
Good Will And Intangible Assets 1.45 Million 1.04 Million 897 Thousand 965 Thousand 1.19 Million
Good Will - - - - -
Intangible Assets 1.45 Million 1.04 Million - - -
Long-Term Investments 1.83 Million 3.47 Million - - -
Tax Assets 35.53 Million 54.2 Million 6.09 Million 7.98 Million 9.59 Million
Other Non Current Assets 202.92 Million 91.36 Million 97.6 Million 72.96 Million 78.42 Million
Other Assets - - - - -
Total Liabilities 547.04 Million 578.38 Million 559.04 Million 410.93 Million 450.25 Million
Total Current Liabilities 451.45 Million 481.89 Million 446.88 Million 292.53 Million 324.75 Million
Account Payables 226.33 Million 75.04 Million 57.54 Million 52.78 Million 58.59 Million
Tax Payables - 18.69 Million 14 Million 9.98 Million 18.96 Million
Short Term Debt 120 Million 288.1 Million 284.91 Million 141.52 Million 163.77 Million
Deferred Revenue 1.17 Million 115.88 Million 99.67 Million 93.79 Million 96.76 Million
Other Current Liabilities 103.95 Million 2.86 Million 4.75 Million 4.42 Million 5.62 Million
Total Non Current Liabilities 95.58 Million 96.48 Million 112.15 Million 118.4 Million 125.49 Million
Long-Term Debt - 2.27 Million 7.28 Million 7.03 Million 8.98 Million
Deferred Revenue Non Current - 9.52 Million 19.94 Million 25.84 Million 30.28 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 19.06 Million 6.83 Million 8.41 Million 8.99 Million 9.7 Million
Other Liabilities - - - - -
Total Equity 1.21 Billion 1.22 Billion 1.1 Billion 1.07 Billion 1.07 Billion
Stock Holders Equity 1.21 Billion 1.22 Billion 1.1 Billion 1.07 Billion 1.07 Billion
Common Stock 569.83 Million 569.83 Million 569.83 Million 569.83 Million 569.83 Million
Retained Earnings 603.18 Million 345.06 Million 254.9 Million 233.07 Million 249.04 Million
Accumulated other comprehensive income -2.8 Million -1.16 Million - - -
Common Stock Equity 1.21 Billion 1.22 Billion 1.1 Billion 1.07 Billion 1.07 Billion
Capital Lease Obligation 2.89 Million 8.38 Million 14 Million 12.53 Million 15.21 Million
Total Investments 1.83 Million 3.47 Million 3.96 Million 3.42 Million 4.45 Million
Total Debt 120 Million 290.37 Million 292.19 Million 148.56 Million 172.75 Million
Net Debt -261.04 Million -165.87 Million 39.92 Million -187.23 Million -102.44 Million

Balance Sheet Charts